Dr. James C. Shaw, MD

Dr. Shaw practices at ROC Surgical Center in Houston, Texas.

Dr. Shaw's NPI, 1952745796, was assigned on April 23, 2013. Dr. Shaw graduated from McGovern Medical School in 2013. Dr. Shaw holds Texas license S3300.

Dr. Shaw's primary practice is ROC Surgical Center, at 1200 Binz Street, Suite 101, Houston, TX 77004. The practice phone is (281) 953-8304.

Dr. Shaw's primary practice is ROC Surgical Center in Houston, Texas. Dr. Shaw is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Shaw to 4 more hospitals, 2 group practices and clinics, 1 home health agency, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shaw practices, 10 sites in all. Vendor and product names are available with a free account.

Orthopaedic trauma is Dr. Shaw's primary specialty in the NPI Registry, under taxonomy code 207XX0801X. Dr. Shaw is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Shaw's licenses on file in 4 states: Texas, Florida, New York and Ohio.

Dmand AI lists arm, wrist, hand fracture and dislocation, back and neck pain treatment without fusion, hip replacement, leg, ankle or foot fracture, muscle pain, fibromyalgia, and limb pain, orthopedic surgery of arms and legs, pelvic and hip fracture and removal of damaged skin or skin graft among the conditions Dr. Shaw treats.

CMS data shows 284 Medicare services from Dr. Shaw across 8 procedure codes in 2024, for 151 Medicare patients. Medicare paid $57,292 for them.

CMS counts 151 Medicare patients who saw Dr. Shaw in 2024. The largest group is 75 to 84, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shaw's median patient age at 68, with 60% women.

In 2024, Dr. Shaw wrote 156 Medicare Part D claims for 71 patients. 99% of them were for generic drugs. CMS names the drug for 136 of them, across 5 drugs with 11 or more claims each, at $973 in total drug cost. In 2023, CMS named 62 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shaw for performance year 2024, reported individually. Dr. Shaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Shaw. The most frequent topics are Ontario and Skin Neoplasms. Dr. Shaw has published most often in Arch Dermatol. Dr. Shaw's most frequent co-authors are Neil Vivek Mohile, MD, Gireesh Bandi Reddy, MD and Ramakanth Reddy Yakkanti, MD.

Dmand AI links Dr. Shaw to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 1 and Autoimmune Diseases.

CMS Open Payments shows 173 general payments to Dr. Shaw from 24 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 60% of the total. Medical Device Business Services, Inc. paid the most, $29,002.

Dr. Shaw graduated from McGovern Medical School in 2013.

Dr. Shaw is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.